Source comparison
Side-by-Side Comparison
Mechanism BDNF upregulation; dopamine/serotonin modulation; neuroprotection GABAergic enhancement; enkephalinase inhibition; cytokine regulation Evidence Grade B+ B Derived From ACTH(4-10) + Pro-Gly-Pro Tuftsin + Pro-Gly-Pro Primary Effect Cognitive enhancemen
This comparison does not assign a generated winner or score.
- Mechanism
- BDNF upregulation; dopamine/serotonin modulation; neuroprotection
- GABAergic enhancement; enkephalinase inhibition; cytokine regulation
- Evidence Grade
- B+
- B
- Derived From
- ACTH(4-10) + Pro-Gly-Pro
- Tuftsin + Pro-Gly-Pro
- Primary Effect
- Cognitive enhancement, focus, neuroprotection
- Anxiolytic, immune modulation, stress reduction
- Route
- Intranasal (primary); subcutaneous
- Typical Dose
- 200 - 600 mcg/day intranasal
- 250 - 500 mcg/day intranasal
- Half-Life
- ~2-3 minutes (plasma); effects last hours
- Best For
- Focus, memory, stroke recovery, ADHD research
- Anxiety, stress, immune support, GAD research
- FDA Status
- Not FDA-approved; approved in Russia
- Cost (research grade)
- $$